
Phibro Animal Health Corporation: updates and filings
Price
$33.29
November 20, 2026Market cap $1.3B
What Ploutos Investor adds for Phibro Animal Health
Part of Ploutos Investor, €9.99 a month
- The full history: 15 fiscal years, from FY2012
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Nov 4, 2026next Feb 4, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
November 2026
August 2026
May 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 4, 2026Results of operations, shareholder voteForm8-K
- Nov 4, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 3, 2026Other material eventsForm8-K
- Oct 19, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Sep 18, 2026Annual report to shareholdersfor the period to Jun 30, 2026FormARS
- Sep 18, 2026Additional annual meeting materialFormDEFA14A
- Sep 18, 2026Annual meeting proxy statementFormDEF 14A
- Aug 26, 2026Results of operationsForm8-K
- Aug 26, 2026Annual reportfor the period to Jun 30, 2026Form10-K
- Aug 6, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Jul 30, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Jul 28, 2026Other material eventsForm8-K
- Jun 26, 2026Officer or director changeForm8-K
- May 22, 2026Over-5% holder statement (active) (amendment)FormSCHEDULE 13D/A
- May 14, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- May 6, 2026Results of operationsForm8-K
- May 6, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- May 5, 2026Other material eventsForm8-K
- Apr 30, 2026Material agreement entered, new material financial obligationForm8-K
- Apr 30, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Apr 27, 2026Regulation FD disclosureForm8-K
- Apr 23, 2026Over-5% holder statement (active) (amendment)FormSCHEDULE 13D/A
- Apr 14, 2026Officer or director changeForm8-K
- Apr 7, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Mar 27, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 4, 2026 | 8-K | Results of operations, shareholder vote | Document |
| Nov 4, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 3, 2026 | 8-K | Other material events | Document |
| Oct 19, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Sep 18, 2026 | ARS | Annual report to shareholdersfor the period to Jun 30, 2026 | Document |
| Sep 18, 2026 | DEFA14A | Additional annual meeting material | Document |
| Sep 18, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Aug 26, 2026 | 8-K | Results of operations | Document |
| Aug 26, 2026 | 10-K | Annual reportfor the period to Jun 30, 2026 | Document |
| Aug 6, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Jul 30, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Jul 28, 2026 | 8-K | Other material events | Document |
| Jun 26, 2026 | 8-K | Officer or director change | Document |
| May 22, 2026 | SCHEDULE 13D/A | Over-5% holder statement (active) (amendment) | Document |
| May 14, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| May 6, 2026 | 8-K | Results of operations | Document |
| May 6, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| May 5, 2026 | 8-K | Other material events | Document |
| Apr 30, 2026 | 8-K | Material agreement entered, new material financial obligation | Document |
| Apr 30, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Apr 27, 2026 | 8-K | Regulation FD disclosure | Document |
| Apr 23, 2026 | SCHEDULE 13D/A | Over-5% holder statement (active) (amendment) | Document |
| Apr 14, 2026 | 8-K | Officer or director change | Document |
| Apr 7, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Mar 27, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Sep 29, 1998.
The full analysis
What do Phibro Animal Health's filings show?
The filings are where every one of Phibro Animal Health's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.